Teva Pharmaceutical Industries reported $807M in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Amarin AMRN:US $ -12.97M 21.83M
Antares Pharma ATRS:US $ 7.22M 1.66M
AstraZeneca AZN:LN 1954M 415M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Novartis NOVN:VX SF 4544M 120M
Patterson Companies PDCO:US $ 53.82M 7.77M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Sun Pharmaceuticals SUNP:IN IR 22865.1M 1487.8M
Supernus Pharmaceuticals SUPN:US $ 28.96M 2.28M
Takeda 4502:JP Y 61447M 161531M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Zoetis ZTS:US $ 717M 11M